Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Teva Recalls a Single Lot of Claravis Capsules
Teva Pharmaceuticals USA Inc. have recalled a single lot of Claravis (isotretinoin), 40 mg capsules. Lot number 701980 has been recalled because this lot failed the manufacturer routine tests that measure the capsules' ability to dissolve. Claravis contains the active ingredient isotretinoin and is commonly used in the treatment of severe acne. Isotretinoin is also sold under other brand names. This recall alert only applies to the single lot of Claravis (isotretinoin), 40 mg capsules. No other isotretinoin products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm230357.htm
Learn More

American Health Packaging Recalls Single Lot of Dronabinol Capsules
American Health Packaging has recalled a single lot of Dronabinol 2.5 mg capsules. Lot number 103869B has been recalled because this lot was stored at below freezing condition which may cause leakage of the substance inside the capsules. Dronabinol is used in the treatment of nausea and vomiting caused by chemotherapy. Dronabinol is also sold under the brand name Marinol. No other lots, strengths, or brands of dronabinol were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm230357.htm
Learn More

Date Published Title Drug Source
2010-10-27 Teva Recalls a Single Lot of Claravis Capsules Isotretinoin FDA
2010-10-27 American Health Packaging Recalls Single Lot of Dronabinol Capsules Dronabinol FDA
2010-10-22 Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/hr Fentanyl Manufacturer
2010-10-21 Warnings of Risk of Abnormal Heart Rhythm Added to Prescribing Information for Invirase Saquinavir FDA
2010-10-21 New Safety Warnings Added to Gonadotropin-Releasing Hormone (GnRH) Agonists Lupron FDA
2010-10-21 Hormone Replacement Therapy After Menopause Associated with Higher Risk of Aggressive Form of Breast Cancer Angeliq MediGuard CRT
2010-10-21 Hormone Replacement Therapy After Menopause Associated with Higher Risk of Aggressive Form of Breast Cancer Estrogens Conjugated with Medroxyprogesterone MediGuard CRT
2010-10-19 McNeil Consumer Healthcare Recalls Single Lot of Tylenol 8 Hour Caplets Acetaminophen Manufacturer
2010-10-15 FDA Provides Answers to Common Questions About Unapproved Chelation Products FDA
2010-10-13 FDA Updates Prescribing Information to Warn of Possible Fracture Risk With Osteoporosis Drugs Ibandronate Sodium FDA
2010-10-10 Pfizer Recalls Several Bottles of Lipitor Because of Strange Smell Atorvastatin Manufacturer
2010-10-08 Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia Sibutramine FDA
2010-10-04 Bristol-Myers Squibb Co. is Recalling 60 Million Tablets of Avalide Hydrochlorothiazide with Irbesartan Manufacturer
2010-10-01 Withdrawal of Unapproved Oral Colchicine Products Colchicine FDA
2010-09-28 Manufacturer Withdraws All Lots of Octagam FDA
2010-09-27 Abbott Voluntarily Recalls Certain Similac Brand Powder Infant Formulas That Did Not Meet Quality Standards Manufacturer
2010-09-24 Amgen Issues Epogen/Procrit Voluntary Recall: Glass Flakes Found in VIals Epoetin Alfa Manufacturer
2010-09-23 Avandia: Restricted Access Program To Be Developed Glimepiride and Rosiglitazone FDA
2010-09-19 FDA Issues Statement on Possible Increased Risk of Rare Bone Fractures with Long-Term Bisphosphonate Use Ibandronate Sodium FDA
2010-09-17 FDA Announces Safety Review of Actos (Pioglitazone) for Cancer Risk Glimepiride and Pioglitazone FDA